Transaction DateRecipientSharesTypePriceValue
1st September 2020David A Gonyer20,238Other acquisition or disposition$1.05$21,249.90
1st September 2020Marilyn R. Carlson20,238Other acquisition or disposition$1.05$21,249.90
1st September 2020Matthew J D'Onofrio20,238Other acquisition or disposition$1.05$21,249.90
2nd March 2020Matthew J D'Onofrio25,000Grant/award etc.$0.85$21,250.00
Evoke Pharma
Evoke Pharma logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.


Evoke Pharma, Inc. develops Gimoti, with promotility and anti-emetic effects. Gimoti is for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus.


Ticker: EVOK
Sector: Health Technology
Industry: Pharmaceuticals: Other
SEC Central Index Key (CIK): 1403708
Employees: 5
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals